Danaher Corporation. (7/14/16). "Press Release: Danaher Announces Appointment of Robert J. Hugin to Danaher Board". Washington, DC.

	Organisation	Danaher Corporation (NYSE: DHR)
	Group	Danaher (Group)
	Product	biopharmaceutical
	Product 2	analytical instrument
	Person	Hugin, Robert J. (Celgene 201006–201603 CEO before COO joined 1999 before JP Morgan + US Marine Corps)
	Person 2	Rales, Steven M. (Danaher 201607 Board Chairman)

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has appointed Robert J. Hugin to Danaher's Board of Directors. The Board also appointed Mr. Hugin to the Compensation Committee of Danaher's Board.

Mr. Hugin serves as the Executive Chairman of the Board of Directors of Celgene Corporation (NASDAQ: CELG). Since joining Celgene in 1999, he has served in a series of progressively more responsible leadership positions including serving as Chief Executive Officer from June 2010 until March 2016. Prior to joining Celgene, Mr. Hugin served as a Managing Director at J.P. Morgan & Co. Inc., which he joined in 1985. From 1976 to 1983, Mr. Hugin served as a United States Marine Corps infantry officer.

Steven M. Rales, Chairman of the Board of Danaher Corporation, said, "We are extremely pleased to welcome Bob to our Board of Directors. With his extensive leadership experience in the biopharmaceutical market, we believe he will be an outstanding asset to our Board and to Danaher."

ABOUT DANAHER

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands have leadership positions in some of the most demanding and attractive industries, including health care, environmental and industrial. With more than 20 operating companies, Danaher's globally diverse team of 59,000 associates is united by a common culture and operating system, the Danaher Business System. For more information please visit www.danaher.com.

Matthew E. Gugino, Vice President, Investor Relations, Danaher Corporation, Telephone: (202) 828-0850, Fax: (202) 828-0860

Record changed: 2016-08-09